ISG to Evaluate AI Services in Healthcare
MWN-AI** Summary
Information Services Group (ISG), a prominent global technology research and advisory firm, has initiated a research study to explore AI service providers in the healthcare sector. Set to publish its findings in the ISG Provider Lens® report titled "AI Services in Healthcare" in April 2026, this study aims to assist healthcare organizations in transitioning from preliminary AI experimentation to full-scale implementation.
The report will evaluate companies that offer comprehensive AI strategy, advisory, development, and delivery services specifically tailored for healthcare. By doing so, it will enable enterprise buyers to assess their existing vendor relationships, explore potential partnerships, and understand the range of available offerings. Healthcare organizations are increasingly leveraging AI to alleviate the demands of clinical duties, enhance operational efficiency, and enrich the patient experience. The adoption of generative AI and agentic AI models has facilitated the automation of routine tasks and improved workflows, particularly in areas such as clinical decision support, imaging, and revenue cycle tasks.
ISG's research will consist of surveys distributed to approximately 100 providers, leading to the creation of two quadrants: Healthcare AI Strategy and Advisory Services, which evaluates providers guiding AI adoption, and Healthcare AI Development and Delivery Services, focusing on those that build and operationalize AI solutions. The findings will encompass a global market overview and will also highlight the needs for strong management and oversight to navigate challenges like data fragmentation and compliance in healthcare.
With over 900 clients, including many of the world’s top enterprises, ISG continues to lead in integrating AI into operational excellence, ensuring enterprises can effectively select their technology service partners.
MWN-AI** Analysis
The upcoming ISG Provider Lens® report on "AI Services in Healthcare," set for release in April 2026, promises to be a critical resource for healthcare enterprises navigating the shifting landscape toward AI-driven care. As a financial analyst, understanding the implications of this report is vital for making informed investment decisions in the healthcare technology sector.
The report will analyze various AI service providers, focusing on their strategies for helping clients transition from initial AI trials to full-scale implementation. The focus on Healthcare AI Strategy and Advisory Services, alongside Healthcare AI Development and Delivery Services, indicates a comprehensive look at both the governance and operationalization stages of AI adoption.
Healthcare organizations are increasingly leveraging AI to alleviate clinical workload, optimize operations, and enhance patient experiences—critical factors as the industry faces data fragmentation and regulatory hurdles. The rise of generative AI and agentic AI models positions these technologies to potentially disrupt traditional healthcare practices. Investors should monitor companies that show a robust understanding of the healthcare domain and can effectively integrate AI with existing systems, such as electronic health records (EHRs).
Moreover, the report will provide insights into vendor relationships and market trends, equipping enterprises with data to evaluate their current partnerships and potential new engagements. For those considering investments in this space, focusing on firms that not only offer AI solutions but also demonstrate a commitment to guardrails and compliance will be imperative.
The increasing demand for tailored AI solutions in areas like clinical decision support and population health suggests that companies recognized in the ISG report may benefit from heightened visibility and growth opportunities. Positioning portfolios to include such leading providers could harness the momentum of AI in healthcare.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Upcoming ISG Provider Lens ® report will examine providers of AI solutions to help healthcare companies move toward data-driven care
Information Services Group ( ISG ) (Nasdaq: III ), a global AI-centered technology research and advisory firm, has launched a research study examining providers that help healthcare enterprises move from early experimentation to real-world adoption of AI.
The study results will be published in a comprehensive ISG Provider Lens ® report, called AI Services in Healthcare, scheduled to be released in April 2026. The report will cover companies offering AI strategy, advisory, development and delivery services to healthcare enterprises.
Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.
Healthcare organizations are rapidly adopting AI to tackle the growing burden of clinical work, address operational pressures and improve patient experience. The gradual uptake of generative AI (GenAI) and agentic AI models, alongside traditional AI, has helped enterprises automate routine tasks and enhance reasoning and orchestration in clinical and operational workflows. Organizations are applying AI in growth areas such as clinical decision support, imaging, virtual care, revenue cycle tasks and population health analysis, supported by tools that are increasingly tailored to healthcare needs. Cloud-based AI platforms and emerging interoperability standards are also strengthening enterprises’ ability to implement AI in a secure and scalable manner.
“Enterprises across the health sector are facing significant challenges, such as data fragmentation and privacy and regulatory constraints,” said Iain Fisher, director at ISG. “As they continue to adopt agentic AI, the need for strong guardrails, oversight and safety management becomes even more critical.”
ISG has distributed surveys to approximately 100 providers. Working in collaboration with ISG’s global advisors, the research team will produce two quadrants representing AI-related services the typical healthcare enterprise is buying, based on ISG’s experience working with its clients. The two quadrants are:
- Healthcare AI Strategy and Advisory Services , evaluating providers that guide organizations in planning and governing AI, GenAI and agentic AI adoption. They offer expertise in selecting and validating healthcare-specific large language models (LLMs), ensuring alignment with clinical, operational and financial goals.
- Healthcare AI Development and Delivery Services , assessing providers that design, build, deploy and operationalize AI solutions for payers and healthcare firms. These providers are further evaluated on their expertise in model development and their ability to integrate these solutions with electronic health records (EHRs), care management platforms and other core systems.
The report produced from the study will cover the global market for AI services in healthcare and examine offerings available worldwide. ISG analysts Rohan Sinha and Sneha Jayanth will serve as authors of the report.
A list of identified providers and vendors and further details on the study are available in this digital brochure . Companies not listed as IT service providers in the healthcare domain can contact ISG and ask to be included in the study.
All 2025 ISG Provider Lens ® evaluations feature expanded customer experience (CX) data that measures actual enterprise experience with specific provider services and solutions, based on ISG’s continuous CX research.
About ISG Provider Lens ® Research
The ISG Provider Lens ® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage .
About ISG
ISG (Nasdaq: III ) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251216699046/en/
Press Contacts:
Laura Hupprich, ISG
+1 203-517-3100
laura.hupprich@isg-one.com
Julianna Sheridan, Matter Communications for ISG
+1 978-518-4520
isg@matternow.com
FAQ**
How does Information Services Group Inc. III plan to evaluate the effectiveness of AI strategy and advisory services in helping healthcare enterprises transition from experimentation to real-world adoption?
What criteria will Information Services Group Inc. III use to assess providers in the Healthcare AI Development and Delivery Services quadrant of the upcoming report?
Can you elaborate on the role of Information Services Group Inc. III's global advisors in the research study and how they contribute to the report's findings for healthcare enterprises?
What specific challenges do healthcare organizations face regarding AI adoption, and how will Information Services Group Inc. III's report address these concerns?
**MWN-AI FAQ is based on asking OpenAI questions about Information Services Group Inc. (NASDAQ: III).
NASDAQ: III
III Trading
-2.68% G/L:
$4.175 Last:
20,458 Volume:
$4.17 Open:
